News

Orion Corporation: Managers’ transactions – Mikael Silvennoinen

ORION CORPORATION MANAGERS’ TRANSACTIONS 11 MAY 2023 at 15.30 EEST          Orion Corporation: Managers’ transactions – Mikael Silvennoinen Orion Corporation…

2 years ago

Orion Corporation: Managers’ transactions – Agendum Oy

ORION CORPORATION MANAGERS’ TRANSACTIONS 11 MAY 2023 at 15.30 EEST          Orion Corporation: Managers’ transactions – Agendum Oy Orion Corporation…

2 years ago

Premier Health’s Subsidiary Canadian Health Care Agency Signs 2-year Agreement in British Columbia

MONTRÉAL, May 11, 2023 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the “Corporation” or “Premier Health”), a…

2 years ago

Grifols Launches AlphaID™ At Home, Enabling U.S. Consumers to Self-Screen for Genetic COPD

Now available in the U.S., this free, innovative genetic health risk service lets consumers screen for their risk of alpha1-antitrypsin…

2 years ago

Femasys Inc. to Showcase Four Products at the American College of Obstetricians and Gynecologists Annual Clinic & Scientific Meeting

ATLANTA, May 11, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs by…

2 years ago

Comera Life Sciences Reports Financial Results for First Quarter 2023 and Recent Business Highlights

– Significant progress in Comera’s ongoing research collaboration with Regeneron, a leading U.S. biotechnology company – – Further development of…

2 years ago

Axis Research & Technologies Announces Integration of OMNIMED™ SmartOR™

Technology Platform Gives Medical Device Companies, Surgeons and Educators Data-Driven Insights to Improve Testing and Training Axis Research & Technologies,…

2 years ago

Aerami Therapeutics to Present Pharmacokinetic Data Supporting AER-901 (Inhaled Imatinib) for Pulmonary Hypertension at the 2023 American Thoracic Society (ATS) International Conference

DURHAM, N.C., May 11, 2023 (GLOBE NEWSWIRE) -- Aerami Therapeutics (“Aerami”), a clinical stage biopharmaceutical company dedicated to breathing life…

2 years ago

Scotiabank donates $1.35M to the MUHC Foundation to create a Montreal without hepatitis C

The transformative gift supports Montréal sans HépC, an ambitious community-based program to prevent and cure hepatitis C cases in Montreal…

2 years ago

Oncocyte Reports First Quarter 2023 Financial Results

Nearing Manufacturing Start Up of First Kitted ProductIRVINE, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision…

2 years ago